Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

10 Stocks to Buy if You Want to Support Companies Taking Covid-19 Seriously  

By Will Ashworth, InvestorPlace Contributor

A recent survey suggests a majority of U.S. companies could mandate vaccines. Here are 10 stocks to buy taking Covid-19 seriously.

Alibaba Stock Is Tough To Recommend Owning Right Now

By Will Ashworth, InvestorPlace Contributor

A recent rape accusation at Alibaba has me wondering if I can continue to support investors owning BABA stock. Here’s why I feel this way.  

Nano Dimension Stock Is a Good Long-Term Buy Here, But Patience Is Key

By Will Ashworth, InvestorPlace Contributor

While there is a safer way to play Nano Dimension and NNDM stock, the CEO’s Q2 2021 message to shareholders might suggest otherwise.

Will Support.com’s Hail Mary Hit the Target?

By Will Ashworth, InvestorPlace Contributor

Support.com’s merger vote is on Sep. 10. While SPRT stock is up more than 1,200% over the past year, one plus one does not equal three.   

Zomedica Continues to Execute Poorly

By Will Ashworth, InvestorPlace Contributor

It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer.

Still Thinking of Buying the Dip in Didi Global? You May Want to Wait.

By Will Ashworth, InvestorPlace Contributor

DIDI stock is one of 10 Chinese stocks I recently recommended investors buy on the dip. Now I'm wondering if that still makes sense.

Did Solana Steal Stellar Lumens’ Thunder This Summer?

By Will Ashworth, InvestorPlace Contributor

Over the summer, Stellar Lumens has gone from competitive cryptocurrency to an also-ran. What happened to make XLM-USD irrelevant?

These 2 Catalysts Get Sofi Technologies to $20 by the End of the Year

By Will Ashworth, InvestorPlace Contributor

SoFi Technologies requires a catalyst or two if SOFI stock is to hit $20 by the end of 2021. Read on to discover what those catalysts might be.

Ethereum Has a Price, But It Isn’t Clear It Has Any Intrinsic Value

By Will Ashworth, InvestorPlace Contributor

A recent article discussed the six reasons Ethereum has intrinsic value. These reasons take investors partway to valuing the cryptocurrency.

Wait to See How the Cassava Sciences Allegations Pan Out

By Will Ashworth, InvestorPlace Contributor

Allegations have been leveled against Cassava Sciences. SAVA stock has fallen by more than 50% as a result. Is this a buy-on-the-dip moment?

Load More